Skip to main content

Table 2 Evoked potentials associated with the SSAS

From: Clinical application of somatosensory amplification in psychosomatic medicine

EEG variables

Means (S.D.) and coefficienta to SSAS (signed)

 

Latency, msec

Amplitude, μV

Somatosensory evoked potential

    

   N9

9.5 (0.7)

(+)

5.1 (2.3)

(-)

   N9–N13

3.8 (0.6)

(+)

1.8 (0.8)

(-)

   N13–N20

5.8 (1.2)

(-)

1.1 (0.7)

(+)

   N20–P23

3.3 (1.2)

(-)

1.2 (0.7)

(+)

Auditory evoked potential

    

   I

1.5 (0.1)

(+)

0.2 (0.1)

(-)

   III

3.7 (0.1)

(-)

0.3 (0.1)

(-)

   V

5.6 (0.2)

(+)

0.6 (1.3)

(-)*

Visual evoked potential

    

   N75

73.2 (10.1)

(-)

3.3 (2.3)

(-)

   P100

103.1 (10.3)

(+)*

5.9 (2.3)

(-)

   N145

138.0 (15.9)

(-)

3.3 (1.7)

(-)

Event-related potential

    

   N100

111.5 (40.6)

(+)

4.2 (2.1)

(-)

   P200

180.3 (45.2)

(+)**

2.9 (1.6)

(+)

   N200

248.1 (51.7)

(+)

4.4 (2.9)

(-)

   P300

333.6 (70.7)

(+)

2.7 (1.8)

(-)**

  1. a The coefficient refers to the partial Pearson's correlation coefficient adjusted for the Toronto alexithymia scale scores and depression and tension-anxiety scores on the Profile of Mood States. A positive (negative) mark indicates a positive (negative) coefficient; *p < 0.10 and **p < 0.05.